We tested 20,000 compounds from a combinatorial SMN2 gene. The SMN2 gene encodes the same protein library, 1040 compounds from a National Institute of (SMN) but produces it at a low efficiency compared Neurological Disorders and Stroke (NINDS) library, 2337 with the SMN1 gene. We performed a high-throughput compounds from our Annotated Compound Library [14], screen of ‫000,74ف‬ compounds to identify those that and 23,685 compounds from our TIC Library, which is increase production of an SMN2-luciferase reporter a composite of compounds purchased from TimTec, protein, but not an SMN1-luciferase reporter protein.
tained some degree of activity and selectivity, but this may have been due to simple hydrolysis in cells and generation of indoprofen (Figure 1) .
Despite the noteworthy increase in SMN2-minigenereporter activity, real-time RT-PCR using SMA patient fibroblasts failed to show an increase in the ratio of fulllength to truncated transcripts, or in the absolute level of transcripts following indoprofen treatment (data not shown). Considering indoprofen's selective activity for SMN2-luc, it is unlikely that indoprofen is acting posttranslationally, as both SMN1-luc and SMN2-luc encode the same protein. We propose that indoprofen has a pre-or cotranslational effect on protein production from SMN2, through a cyclooxygenase-independent mechanism. For example, it is possible that indoprofen, resembling a nucleotide, binds to the SMN2 pre-mRNA and displaces proteins that reduce the rate of translation. We sought evidence as to whether indoprofen also affects the level of endogenous SMN protein in human cells.
Indoprofen Increases SMN Protein Level in Human Type I SMA Patient Fibroblasts
To assess whether indoprofen treatment affected SMN protein production, we treated type I SMA patient fibroblasts (3813) with indoprofen and assessed protein level by Western blotting (Figure 2) . We treated 3813 cells with 5 and 20 M indoprofen for 3 days with daily media and compound changes, even though liquid chromatography-mass spectroscopy (LC-MS) revealed that there was no significant degradation of indoprofen over 4 days in cell culture medium (data not shown). Both concentrations of indoprofen treatments yielded similar effects on SMN protein increase, although occasionally higher levels were observed from either treatment concentration (Figure 2 ). Combining data from both treatments, indoprofen-treated cells resulted in a mean 13% increase in SMN protein production versus untreated cells (independent, one-tailed t test; n ϭ 17 [9 treated samples, 8 control samples], ϭ 15, p Ͻ 0.014).
Indoprofen Increases Number of Nuclear Gems in Human Type I SMA Patient Fibroblasts
The increase in SMN protein production led us to inquire about the effect of indoprofen on the overall number of Pooling the two treatments also generated a significant result (independent, one-tailed t test; n ϭ 24 [15 treated, Methyl, ethyl, and isopropyl esters of indoprofen re- 
; TgSMN2
Ϫ/Ϫ mice. Our SMA model mice assay that detects production of an SMN-luciferase were derived from the published transgenic model crereporter protein, and we used this assay to identify ated in C57BL/6 and crossed with FVB (Taconic Labs) compounds that increase production of SMN protein [16]. These mice were backcrossed once with a wildin cells. In a screen of ‫000,74ف‬ compounds, we discovtype FVB mouse to generate our C57BL/6/FVB mice.
ered that a nonsteroidal anti-inflammatory drug (indoWe found that in this strain of Smn 
